Agrin loss in Barrett's esophagus-related neoplasia and its utility as a diagnostic and predictive biomarker.
Steffen RickeltAzfar NeyazCharlene CondonCharles A WhittakerBlair A JobeMartin S TaylorGenevieve AbbruzzeseAnthony R MattiaLawrence ZukerbergStuti G ShroffÖmer H YilmazOsman YılmazElizabeth Y WuWon-Tak ChoiBlair A JobeRobert D OdzeDeepa T PatilVikram DeshpandeRichard O HynesPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
We highlight ECM changes during BE progression to neoplasia. BM AGRN loss is a novel diagnostic biomarker that can identify NDBE patients at increased risk of developing advanced neoplasia.
Keyphrases